U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07805707) titled 'A Study on the Efficacy of a Vaccine Against Influenza in Adults >=65 Years of Age' on Sept. 01.
Brief Summary: This study will compare an investigational mRNA flu vaccine with a licensed flu vaccine in adults 65 years of age and older. Participants will receive one injection and will be followed during the flu season. The study will measure prevention of laboratory-confirmed flu illness, side effects, and immune responses.
Study Start Date: Sept. 02
Study Type: INTERVENTIONAL
Condition:
Influenza, Human
Intervention:
COMBINATION_PRODUCT: mRNA Seasonal Flu vaccine
Single-dose intramuscular administration of the season-adapted...